Ring-type Pulse Oximeter for Evaluation for Sleep Assessment Study (ROSA)

Belun Technology

Status: Completed

Conditions: Sleep-Disordered Breathing; Sleep Architecture

Treatments: Device: Belun Ring Pulse Oximeter

Study type: Interventional

Funder types: Other

Identifiers

NCT06221124

SPO#179613

Details and patient eligibility

About

Recently, various electronic lifestyle activity monitoring devices (ELAM) are increasingly commercially available. However, the quality and reliability of the data from ELAM are unclear, compared with polysomnography (PSG), which is the gold-standard sleep assessment method. Thus, combining ELAM with PSG will validate ELAM and improve its clinical and research utilization.

The investigators propose to conduct this study to validate ELAM device for sleep assessment. The investigators will compare Belun Ring data collection and overnight in-lab PSG measures of Sleep-Disordered Breathing (SDB) and sleep architecture in adults with obstructive sleep apnea (OSA) symptoms.

The investigators propose to recruit a total of 40 participants with symptoms of OSA. The overall accuracy, sensitivity and specificity of Belun Ring to assess SDB and sleep architecture will be validated by using PSG analysis as a gold standard.

Enrollment: 40 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age between 18 to 80 years old. Ideally balanced for sex and age (18 to 80 years old)
• no more than 75% of subjects in one bin of: (male, female)
• no more than 50% of subjects in one age-group (18-29, 30-39, 40-49, 50-59, 60-80)
• Patients with OSA symptoms (snoring, excessive daytime sleepiness or witnessed apnea, etc.)
• Without any unstable medical or psychiatric co-morbidities that would be expected to interfere with the study.
• If taking any medication, must be on a stable dose of medication for a month
• Able to read and understand English

Exclusion criteria

• Presence of any significant systemic or unstable medical condition which could lead to difficulty complying with the protocol, suicidality, current regular use of psychiatric medications, opiates, or thyroid medications, dementia, current substance abuse, post-traumatic or psychotic disorders, bipolar disorder; any significant neurologic disease, including possible and probable dementia, Parkinson's or Huntington's disease, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, history of significant head trauma, history of alcohol or substance use disorder within the past 2 years (DSM V criteria);
• If positive airway pressure (PAP) titration study or split night study (diagnostic and PAP titration study combined)

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

40 participants in 1 patient group

BEL-Participant

Experimental group

Description:

First, we will measure the size of the finger of the participant and select appropriate size of Belun Ring device and the participant will be instructed to wear it on a finger in addition to regular PSG set up on the night of sleep study. Simultaneous recording of Belun Ring data {pulse oximeter, pulse rate and actigraphy} and standard PSG will be performed for one night.

Treatment:

Device: Belun Ring Pulse Oximeter